Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1986-10-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0193-5216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
34-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3744298-Adult,
pubmed-meshheading:3744298-Dantrolene,
pubmed-meshheading:3744298-Fluphenazine,
pubmed-meshheading:3744298-Humans,
pubmed-meshheading:3744298-Male,
pubmed-meshheading:3744298-Neuroleptic Malignant Syndrome,
pubmed-meshheading:3744298-Recurrence,
pubmed-meshheading:3744298-Schizophrenia
|
pubmed:year |
1986
|
pubmed:articleTitle |
Dantrolene sodium as a possible prophylactic agent against N.M.S.
|
pubmed:publicationType |
Journal Article,
Case Reports
|